Physician profile
Brian Hwang
NPI 1548421969
$8,687.10
in general payments reported to CMS, 2019-2025
18 companies · $121 in 2025
The $121 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,796 · 2020: $44.44 · 2021: $154 · 2022: $1,465 · 2023: $1,330 · 2024: $777 · 2025: $121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,593 · Travel and Lodging: $635.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,593.36 |
| Travel and Lodging | $634.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $4,535.16 | 2019-2022 | |
| Abbvie INC. | $1,079.29 | 2023-2024 | |
| Sientra, INC. | $823.25 | 2019-2022 | |
| Tela Bio, INC. | $579.95 | 2022-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Tepha INC | $405.55 | 2019 | |
| Medtronic, INC. | $246.72 | 2023-2024 | Intellis Adaptivestim |
| Motiva USA, LLC | $225.23 | 2024-2025 | |
| Mentor Worldwide LLC | $185.34 | 2019-2024 | Mentor Memorygel Resterilizable Gel Sizer |
| Solta Medical, A Division of Bausch Health US, LLC | $176.40 | 2024 | |
| Abbott Laboratories | $137.90 | 2023-2025 | Proclaim, Eterna |
| Sumitomo Pharma America, INC. | $84.13 | 2023-2025 | Myfembree, Gemtesa |
| Myovant Sciences INC. | $50.56 | 2022 | |
| Hologic Sales and Service, LLC | $44.86 | 2021 | |
| Vioptix INC | $33.69 | 2019 | |
| Agile Therapeutics, INC. | $31.75 | 2023-2024 | Twirla |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $17.52 | 2023 | Seglentis |
| Spineology INC. | $15.99 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $13.81 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Hwang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.